Partnership announced to develop vaccines for MERS and Lassa fever
by Press Release from Outbreak News Today on (#3HJBF)
Themis Bioscience and CEPI - the Coalition for Epidemic Preparedness Innovations - announced today a partnership under which Themis will provide advanced vaccine development and manufacturing for Lassa fever and MERS. This is the first company agreement that CEPI has signed since it was established in 2017 as a coalition to finance and coordinate the development ["]
The post Partnership announced to develop vaccines for MERS and Lassa fever appeared first on Outbreak News Today.